InsiderClue
Insiders · Profile

YOUNG KEVIN

Director at Quince Therapeutics · EVP, Commercial Operations at Gilead Sciences. Filing since 20 Feb 2007. CIK 0001303643

QNCX Quince Therapeutics, Inc. Director · 1 trade GILD Gilead Sciences EVP, Commercial Operations · 19 trades
Company
Date
Role
Action
Shares
Amount
Of holding
QNCX Quince Therapeutics, Inc.
13 May 2019
Director
Bought
30,000
$510.00K
opened
GILD Gilead Sciences
23 Jan 2014
EVP, Commercial Operations
Sold, plan not stated
100,000
$8.14M
31.6%
GILD Gilead Sciences
20 Dec 2013
EVP, Commercial Operations
Sold, plan not stated
75,000
$5.56M
31.7%
GILD Gilead Sciences
22 Nov 2013
EVP, Commercial Operations
Sold, plan not stated
75,000
$5.58M
31.7%
GILD Gilead Sciences
23 Oct 2013
EVP, Commercial Operations
Sold, plan not stated
75,000
$5.14M
31.7%
GILD Gilead Sciences
23 Sep 2013
EVP, Commercial Operations
Sold, plan not stated
100,000
$6.29M
38.2%
GILD Gilead Sciences
19 Nov 2012
EVP, Commercial Operations
Sold, plan not stated
360,000
$26.75M
83.0%
GILD Gilead Sciences
16 Nov 2012
EVP, Commercial Operations
Sold, plan not stated
100,746
$7.52M
57.8%
GILD Gilead Sciences
1 Dec 2009
EVP, Commercial Operations
Sold, plan not stated
75,000
$3.44M
78.7%
GILD Gilead Sciences
5 Oct 2009
EVP, Commercial Operations
Sold, plan not stated
30,000
$1.34M
59.6%
GILD Gilead Sciences
9 Jul 2009
EVP, Commercial Operations
Sold, plan not stated
30,000
$1.34M
59.6%
GILD Gilead Sciences
3 Apr 2009
EVP, Commercial Operations
Sold, plan not stated
30,000
$1.42M
60.2%
GILD Gilead Sciences
7 Jan 2009
EVP, Commercial Operations
Sold, plan not stated
30,000
$1.50M
70.1%
GILD Gilead Sciences
6 Oct 2008
EVP, Commercial Operations
Sold, plan not stated
30,000
$1.36M
70.1%
GILD Gilead Sciences
8 Jul 2008
EVP, Commercial Operations
Sold, plan not stated
30,000
$1.55M
70.1%
GILD Gilead Sciences
10 Apr 2008
EVP, Commercial Operations
Sold, plan not stated
30,000
$1.55M
71.4%
GILD Gilead Sciences
7 Jan 2008
EVP, Commercial Operations
Sold, plan not stated
30,000
$1.40M
86.4%
GILD Gilead Sciences
9 Oct 2007
EVP, Commercial Operations
Sold, plan not stated
30,000
$1.25M
86.5%
GILD Gilead Sciences
3 Jul 2007
EVP, Commercial Operations
Sold, plan not stated
30,000
$1.18M
86.5%
GILD Gilead Sciences
20 Feb 2007
EVP, Commercial Operations
Sold, plan not stated
30,000
$2.17M
93.8%
20 decisions on file.